Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 29.50% is 26% above its 5-year average of 23.46%, near the high end of its 5-year range (-43.70%–37.47%).
124.05% above its 12-month average of 13.17%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): -43.70%.
GROSS MARGIN
29.50%
GROSS MARGIN AVG TTM
13.17%
GROSS MARGIN AVG 3Y
25.04%
GROSS MARGIN AVG 5Y
23.46%
GROSS MARGIN AVG 10Y
22.81%
GROSS MARGIN AVG 15Y
26.83%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+124.05%
CURRENT VS 3Y AVG
+17.79%
CURRENT VS 5Y AVG
+25.77%
CURRENT VS 10Y AVG
+29.34%
CURRENT VS 15Y AVG
+9.94%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-28.71%
vs the sector median at left
Market Cap
$24.44M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$25.22M
Gross Margin
0.00%
TTM Avg
49.92%
3Y Avg
18.04%
5Y Avg
44.48%
Market Cap
$23.38M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
99.50%
5Y Avg
86.48%
Market Cap
$23.06M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$22.25M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$27.03M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InspireMD, Inc. (NSPR) | $24.60M | 29.50% | 13.17% | 25.04% | 23.46% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.13M | 91.37% | 69.42% | 78.99% | 53.34% |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | 0.00% | 49.92% | 18.04% | 44.48% |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.38M | 100.00% | 100.00% | 99.50% | 86.48% |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| LeonaBio, Inc. (LONA)vs › | $22.68M | 0.00% | 0.00% | 0.00% | 0.00% |
| Modular Medical, Inc. (MODD)vs › | $22.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $27.03M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | 63.95% | 66.50% | 67.57% | 61.13% |
Gross Margin
29.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | -43.70% |
| 2026-03-31 | 20.22% |
| 2025-12-31 | 37.47% |
| 2025-09-30 | 34.24% |
| 2025-06-30 | 17.60% |
| 2025-03-31 | 19.10% |
| 2024-12-31 | 24.06% |
| 2024-09-30 | 22.87% |
| 2024-06-30 | 19.03% |
| 2024-03-31 | 19.32% |
| 2023-12-31 | 28.68% |
| 2023-09-30 | 28.15% |
| 2023-06-30 | 29.78% |
| 2023-03-31 | 30.10% |
| 2022-12-31 | 19.30% |
| 2022-09-30 | 25.58% |
| 2022-06-30 | 28.15% |
| 2022-03-31 | 10.31% |
| 2021-12-31 | 21.30% |
| 2021-09-30 | 8.59% |
| 2021-06-30 | 25.24% |
| 2021-03-31 | 10.54% |
| 2020-12-31 | -246.84% |
| 2020-09-30 | 30.41% |
| 2020-06-30 | -38.34% |
| 2020-03-31 | 28.53% |
| 2019-12-31 | 25.57% |
| 2019-09-30 | 13.63% |
| 2019-06-30 | 32.64% |
| 2019-03-31 | -17.59% |
| 2018-12-31 | 27.62% |
| 2018-09-30 | 25.75% |
| 2018-06-30 | 27.62% |
| 2018-03-31 | 29.10% |
| 2017-12-31 | 25.21% |
| 2017-09-30 | 21.31% |
| 2017-06-30 | 22.97% |
| 2017-03-31 | 13.01% |
| 2016-12-31 | -17.39% |
| 2016-09-30 | 6.61% |
| 2016-06-30 | 11.48% |
| 2016-03-31 | 11.72% |
| 2015-12-31 | -26.36% |
| 2015-09-30 | 14.08% |
| 2015-06-30 | -30.95% |
| 2015-03-31 | -7.76% |
| 2014-12-31 | 45.29% |
| 2014-09-30 | -27.84% |
| 2014-06-30 | -202.59% |
| 2014-03-31 | 57.83% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 51.68% |
| 2013-06-30 | 44.53% |
| 2013-03-31 | 55.48% |
| 2012-12-31 | 59.48% |
| 2012-09-30 | 54.81% |
| 2012-06-30 | 56.81% |
| 2012-03-31 | 49.56% |
| 2011-12-31 | 48.07% |
| 2011-09-30 | 59.67% |
| 2011-06-30 | 38.46% |
| 2011-03-31 | 46.68% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |